Product Images Docetaxel

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 19 images provide visual information about the product associated with Docetaxel NDC 23155-905 by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

160mg-8mL-carton.jpg - 160mg 8mL carton

160mg-8mL-carton.jpg - 160mg 8mL carton

This text provides information about Docetaxel Injection, a medication used for intravenous use to treat certain types of cancer. The text includes details on dosage, administration, composition, manufacturer details, and storage instructions. Docetaxel Injection is available in single-dose vials and should be discarded if unused. It contains docetaxel, anhydrous citric acid, polysorbate 80, and dehydrated alcohol. The text also includes warnings about handling the medication as it is a cytotoxic agent and should be kept out of reach of children. Storage instructions recommend keeping it between 2-25 °C and protected from light.*

160mg-8mL-vial.jpg - 160mg 8mL vial

160mg-8mL-vial.jpg - 160mg 8mL vial

This text contains information on a medication called Docetaxel, which is an injection solution with a concentration of 20 mg per milliliter. It is indicated for intravenous use only and is ready to be added to an infusion solution. The manufacturer is Avet Pharmaceuticals Inc., based in East Brunswick, NJ, with contact information provided. The medication is made in China. The text also advises to discard any unused portion and refers to the package insert for complete instructions. The revision date is 11/2024.*

20mg-mL-carton - 20mg mL carton

20mg-mL-carton - 20mg mL carton

The text is a pharmaceutical label for a product called "Docetaxel" from Sichuan Huiyu Pharmaceutical Co., Ltd. It contains information about the dosage, administration, and ingredients of the product. The label specifies that it is an injection solution for intravenous use only and gives instructions on how to prepare and administer the medication. The product is ready to add to an infusion solution. It also provides contact information for any queries or further instructions.*

20mg-mL-vial.jpg - 20mg mL vial

20mg-mL-vial.jpg - 20mg mL vial

80mg-4mL-carton.jpg - 80mg 4mL carton

80mg-4mL-carton.jpg - 80mg 4mL carton

This text is a detailed description of Docetaxel Injection, a medication used for intravenous use only. It contains 80 mg/4 mL and is ready to be added to an infusion solution. The manufacturer is Avet Pharma. The text also includes information about the composition of the solution and instructions for dosage and administration. The storage conditions and precautions are also mentioned.*

80mg-4mL-vial.jpg - 80mg 4mL vial

80mg-4mL-vial.jpg - 80mg 4mL vial

This text seems to be a label or package information for an injection manufactured by Avet Pharmaceuticals Inc. It contains details such as the address, phone number, dosage (20 mg/mL), expiration date (01/2024), and instructions for use. It is recommended to consult the package insert for complete instructions before using the medication.*

Avet logo - Avet logo

Avet logo - avet logo

Figure 1 - figure 1

Figure 1 - figure 1

Figure 10 - figure 10

Figure 10 - figure 10

Figure 2 - figure 2

Figure 2 - figure 2

This is a graph showing survival probability (%) over different survival times (months). It provides insight into the likelihood of survival over specific time intervals.*

Figure 3 - figure 3

Figure 3 - figure 3

Figure 4 - figure 4

Figure 4 - figure 4

Figure 5 - figure 5

Figure 5 - figure 5

This is chart displaying survival time in months. The data points are given at intervals of 3, 6, 12, 18, 21, and 27 months.*

Figure 6 - figure 6

Figure 6 - figure 6

Figure 7 - figure 7

Figure 7 - figure 7

Figure 8 - figure 8

Figure 8 - figure 8

This text provides data on the Progression Free Survival (PFS) probability in percentage (%) at different time points (in months) – 12, 18, 24, 30. It shows a decreasing trend in PFS probability over time, with values ranging from 0% to 100%.*

Figure 9 - figure 9

Figure 9 - figure 9

This text provides survival probability percentages at different survival times in months. It shows the survival probability at time points such as 24, 30, 36, 42, 48, 54, and 60 months.*

structural formula - structural formula

structural formula - structural formula

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.